Histone Deacetylase Inhibitors in Cancer Therapy

By Fouladi Maryam  

Cancer Investigation, Vol. 24, Iss. 5, 2006-06 ,pp. : 521-527

Informa Healthcare

Access to resources Recommend Favorite

Superior antimitogenic and chemosensitization activities of the combination treatment of the histone deacetylase inhibitor apicidin and proteasome inhibitors on human colorectal cancer cells

By      

International Journal of Oncology, Vol. 44, Iss. 1, 2014-01 ,pp. : 105-128

Spandidos Publications

Access to resources Recommend Favorite

Selective Histone Deacetylase Inhibitors

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 12, Iss. 3, 2012-01 ,pp. : 247-270

Bentham Science Publishers

Access to resources Recommend Favorite

Histone Deacetylase Inhibitors: Design, Structure-Activity Relationships and Therapeutic Implications for Cancer

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 9, Iss. 6, 2009-07 ,pp. : 661-692

Bentham Science Publishers

Access to resources Recommend Favorite

Molecular Probing and Imaging of Histone Deacetylase Inhibitors in Cancer Treatment

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 12, Iss. 3, 2012-01 ,pp. : 182-186

Bentham Science Publishers

Access to resources Recommend Favorite